Cormorant Asset Management, LP Cullinan Oncology, Inc. Transaction History

Cormorant Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $17.6 Million - $33 Million	1,125,000 New	1,125,000 $19.6 Million
Q2 2021 Aug 16, 2021	SELL	$24.96 - $41.25 $3.74 Million - $6.19 Million	-150,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $4.2 Million - $8.01 Million	150,000 New	150,000 $6.25 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.